Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
PaperCitations, authors & open-access status
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 73 citations, 2021 year and gold oa status.
73
Citations
2021
Year
gold
OA Status